Endiatx

Endiatx

Private
Hayward, CaliforniaHealthcare & Life Scienceshttps://endiatx.com

Last Round

VC Round

May 22, 2025

Total Funding Raised

$4.19M

Company Overview

Endiatx is a medical device company that develops pill-sized robots for diagnostics and treatment of the gastrointestinal tract.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Telemedicine, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Data as a Service

AI Layer

Non-AI

Keywords

robotic pillcapsule endoscopyswallowable cameracamera pillendoscopy alternativeremote diagnosisGI tract visualizationsedation-free endoscopymedical roboticstele-endoscopygastroenterology devicemicroroboticsactive navigationdisposable medical devicemedical imaging device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Endiatx Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Endiatx Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 22, 2025
Series AJun 28, 2024
VC RoundJan 8, 2024
SeedJun 16, 2023
SeedApr 29, 2022
Seed
Apr 10, 2020

Key People

Founding team and executive leadership

Christopher Green

Founder, Chief Business Officer

Founding Team

Endiatx Investors

Notable investors and investment history

InvestorRounds
MedTech InnovatorSeed
Verge HealthTech FundSeries A, Seed
Founder InstituteSeed
Varia VenturesVC Round
The SINC FundSeries A, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 23, 2026

    Open roles increased to 11, 31% of headcount.

Endiatx Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Endiatx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Endiatx's valuation, stock price, and market status.

Firmographic Details

HeadquartersHayward, California
Employee Range36
Year Founded2019
Last FundingMay 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.